Odyssey Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	41.69	59.14	52.55	241.04
Short-Term Investments	139.67	70.22	134.45	-
Cash & Short-Term Investments	181.36	129.35	187	241.04
Cash Growth	40.20%	-30.83%	-22.42%	-
Other Current Assets	9.3	6.16	5.54	7.67
Total Current Assets	190.66	135.51	192.54	248.71
Net Property, Plant & Equipment	26.01	39.47	46.73	52.77
Other Intangible Assets	0.26	0.57	0.91	1.18
Goodwill	14.33	13.35	13.55	12.88
Long-Term Investments	35.2	-	29.1	-
Other Long-Term Assets	3.33	8.54	3.69	1.61
Total Assets	269.79	197.44	286.52	317.15
Accounts Payable	7.87	6.32	7.73	8.05
Accrued Expenses	13.39	17.52	10.5	11.39
Current Portion of Leases	5.21	4.58	3.86	1.72
Other Current Liabilities	-	-	-	1.63
Total Current Liabilities	26.48	28.42	22.09	22.8
Long-Term Debt	-	-	-	4.76
Long-Term Leases	21.9	26.43	30.52	34.38
Other Long-Term Liabilities	6.13	10.22	8.41	8.2
Total Long-Term Liabilities	28.03	36.65	38.94	47.34
Total Liabilities	54.51	65.07	61.02	70.14
Common Stock	-	-	0	0
Additional Paid-in Capital	79.62	38.31	27.24	15.73
Accumulated Other Comprehensive Income	0.25	-1.34	-0.86	-2.18
Retained Earnings	-568.14	-419.49	-289.09	-158.17
Total Common Shareholders' Equity	-488.28	-382.53	-262.71	-144.62
Minority Interest	703.56	514.89	488.21	391.63
Shareholders' Equity	215.28	132.37	225.5	247.01
Total Liabilities & Equity	269.79	197.44	286.52	317.15

SEC Filings: 10-K · 10-Q